Icecure Medical is trading at $3.45, up +5.18%, as investors position ahead of its first-half 2026 financial and operating results scheduled before market open on August 12, 2026.
- The company will discuss results and corporate developments during a conference call that morning.
- Shares gained 6.49% on August 10, 2026, indicating continued pre-results momentum despite broader U.S. equities trading lower.